Dinaciclib Synergizes with BH3 Mimetics Targeting BCL-2 and BCL-XL in Multiple Myeloma Cell Lines Partially Dependent on MCL-1 and in Plasma Cells from Patients.

Manuel Beltran-Visiedo,Nelia Jimenez-Alduan,Rosana Diez,Marta Cuenca,Andrea Benedi,Alfonso Serrano-Del Valle,Gemma Azaceta,Luis Palomera,Victor Peperzak,Alberto Anel,Javier Naval,Isabel Marzo

Molecular oncology（2023）

引用 0|浏览36

暂无评分

关键词

BCL-2 proteins,BH3 mimetics,CDK inhibitors,cell death,multiple myeloma

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要